R. John Fletcher's Insider Trades & SAST Disclosures
R. John Fletcher's most recent trade in KORU Medical Systems Inc was a trade of 8,806 Common Stock done at an average price of $2.6 . Disclosure was reported to the exchange on April 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern R. John Fletcher.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| KORU Medical Systems Inc | R. John Fletcher | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 2.56 per share. | 02 Apr 2025 | 8,806 | 205,562 (0%) | 0% | 2.6 | 22,543 | Common Stock |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 11.89 per share. | 01 Apr 2025 | 486 | 94,398 (0%) | 0% | 11.9 | 5,779 | Common Stock |
| KORU Medical Systems Inc | R. John Fletcher | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 3.81 per share. | 03 Jan 2025 | 5,905 | 196,756 (0%) | 0% | 3.8 | 22,498 | Common Stock |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 15.38 per share. | 02 Jan 2025 | 375 | 93,912 (0%) | 0% | 15.4 | 5,768 | Common Stock |
| KORU Medical Systems Inc | R. John Fletcher | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 2.75 per share. | 01 Oct 2024 | 8,181 | 190,851 (0%) | 0% | 2.8 | 22,498 | Common Stock |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 11.21 per share. | 01 Oct 2024 | 515 | 93,537 (0%) | 0% | 11.2 | 5,773 | Common Stock |
| KORU Medical Systems Inc | R. John Fletcher | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 2.71 per share. | 11 Jul 2024 | 8,371 | 182,670 (0%) | 0% | 2.7 | 22,685 | Common Stock |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 5.39 per share. | 01 Jul 2024 | 1,072 | 93,022 (0%) | 0% | 5.4 | 5,778 | Common Stock |
| OptiNose Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 85,000 | 85,000 | - | - | Stock Option (Right to Buy) | |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 21,093 | 21,093 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2024 | 17,153 | 91,950 (0%) | 0% | - | Common Stock | |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2024 | 17,153 | 0 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 6.80 per share. | 01 Apr 2024 | 850 | 74,797 (0%) | 0% | 6.8 | 5,780 | Common Stock |
| KORU Medical Systems Inc | R. John Fletcher | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 2.37 per share. | 31 Mar 2024 | 9,493 | 174,353 (0%) | 0% | 2.4 | 22,498 | Common Stock |
| ClearPoint Neuro Inc | John Fletcher R. | Director | Grant, award, or other acquisition of securities at price $ 6.79 per share. | 02 Jan 2024 | 851 | 73,947 (0%) | 0% | 6.8 | 5,778 | Common Stock |
| KORU Medical Systems Inc | John Fletcher R. | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 2.37 per share. | 31 Dec 2023 | 9,493 | 164,860 (0%) | 0% | 2.4 | 22,498 | Common Stock |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 7.24 per share. | 03 Jul 2023 | 798 | 71,943 (0%) | 0% | 7.2 | 5,778 | Common Stock |
| KORU Medical Systems Inc | R. John Fletcher | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 3.48 per share. | 30 Jun 2023 | 6,465 | 147,141 (0%) | 0% | 3.5 | 22,498 | Common Stock |
| OptiNose Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 53,500 | 53,500 | - | - | Stock Option (Right to Buy) | |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 17,153 | 17,153 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 8.44 per share. | 03 Apr 2023 | 684 | 71,145 (0%) | 0% | 8.4 | 5,773 | Common Stock |
| KORU Medical Systems Inc | R. John Fletcher | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 4.26 per share. | 31 Mar 2023 | 5,281 | 140,676 (0%) | 0% | 4.3 | 22,497 | Common Stock |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 7.97 per share. | 03 Jan 2023 | 2,175 | 70,461 (0%) | 0% | 8.0 | 17,335 | Common Stock |
| KORU Medical Systems Inc | R. John Fletcher | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 3.51 per share. | 31 Dec 2022 | 6,410 | 135,395 (0%) | 0% | 3.5 | 22,499 | Common Stock |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 10.19 per share. | 03 Oct 2022 | 1,702 | 68,286 (0%) | 0% | 10.2 | 17,343 | Common Stock |
| KORU Medical Systems Inc | R. John Fletcher | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 2.25 per share. | 30 Sep 2022 | 10,022 | 128,985 (0%) | 0% | 2.3 | 22,550 | Common Stock |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 12.63 per share. | 01 Jul 2022 | 1,373 | 66,584 (0%) | 0% | 12.6 | 17,341 | Common Stock |
| KORU Medical Systems Inc | R. John Fletcher | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 2.50 per share. | 30 Jun 2022 | 9,003 | 118,963 (0%) | 0% | 2.5 | 22,508 | Common Stock |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 9,269 | 65,211 (0%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 6,179 | 6,179 | - | - | Stock Options (right to buy) | |
| OptiNose Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 64,000 | 64,000 | - | - | Stock Option (Right to Buy) | |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 9.96 per share. | 01 Apr 2022 | 1,741 | 55,942 (0%) | 0% | 10.0 | 17,340 | Common Stock |
| KORU Medical Systems Inc | R. John Fletcher | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 2.87 per share. | 31 Mar 2022 | 7,832 | 109,960 (0%) | 0% | 2.9 | 22,478 | Common Stock |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 11.54 per share. | 01 Jan 2022 | 2,003 | 54,201 (0%) | 0% | 11.5 | 23,115 | Common Stock |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 17.92 per share. | 01 Oct 2021 | 1,290 | 52,198 (0%) | 0% | 17.9 | 23,117 | Common Stock |
| KORU Medical Systems Inc | R. John Fletcher | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 2.85 per share. | 30 Sep 2021 | 7,894 | 94,628 (0%) | 0% | 2.9 | 22,498 | Common Stock |
| KORU Medical Systems Inc | R. John Fletcher | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 4.63 per share. | 30 Jun 2021 | 3,744 | 86,734 (0%) | 0% | 4.6 | 17,335 | Common Stock |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 20.26 per share. | 30 Jun 2021 | 771 | 50,908 (0%) | 0% | 20.3 | 15,620 | Common Stock |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 6,006 | 6,006 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 3,003 | 50,137 (0%) | 0% | 0 | Common Stock | |
| KORU Medical Systems Inc | R. John Fletcher | Director, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 4.30 per share. | 17 May 2021 | 25,000 | 82,990 (0%) | 0% | 4.3 | 107,500 | Common Stock |
| KORU Medical Systems Inc | R. John Fletcher | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 3.52 per share. | 31 Mar 2021 | 3,551 | 57,990 (0%) | 0% | 3.5 | 12,500 | Common Stock |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 19.57 per share. | 31 Mar 2021 | 738 | 47,134 (0%) | 0% | 19.6 | 14,443 | Common Stock |
| Axcelis Technologies Inc | R. John Fletcher | Director | Sale of securities on an exchange or to another person at price $ 39.00 per share. | 17 Feb 2021 | 6,881 | 1,354 (0%) | 0% | 39 | 268,359 | Common Stock |
| KORU Medical Systems Inc | R. John Fletcher | Director, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 4.48 per share. | 30 Nov 2020 | 21,052 | 50,050 (0%) | 0% | 4.5 | 94,313 | Common Stock |
| KORU Medical Systems Inc | R. John Fletcher | Director, Chairman of the Board | Purchase of securities on an exchange or from another person at price $ 4.53 per share. | 30 Nov 2020 | 1,275 | 51,325 (0%) | 0% | 4.5 | 5,776 | Common Stock |
| KORU Medical Systems Inc | R. John Fletcher | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 7.22 per share. | 30 Sep 2020 | 2,597 | 28,998 (0%) | 0% | 7.2 | 18,750 | Common Stock |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 5.71 per share. | 30 Sep 2020 | 2,124 | 45,588 (0%) | 0% | 5.7 | 12,128 | Common Stock |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 5.71 per share. | 30 Sep 2020 | 2,124 | 45,588 (0%) | 0% | 5.7 | 12,128 | Common Stock |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 3.55 per share. | 30 Jun 2020 | 3,411 | 43,464 (0%) | 0% | 3.5 | 12,109 | Common Stock |
| KORU Medical Systems Inc | R. John Fletcher | Other, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 8.98 per share. | 30 Jun 2020 | 2,088 | 26,401 (0%) | 0% | 9.0 | 18,750 | Common Stock |
| ClearPoint Neuro Inc | R. John Fletcher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2020 | 15,000 | 15,000 | - | - | Stock Options (right to buy) | |
| Axcelis Technologies Inc | R. John Fletcher | Director | Sale of securities on an exchange or to another person at price $ 26.52 per share. | 28 May 2020 | 50,750 | 8,235 (0%) | 0% | 26.5 | 1,345,890 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges